Srx Health Solutions Inc (SRXH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2019 | 03-2019 | 02-2019 | 12-2018 | 11-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -164,313 | -2,776 | 339 | N/A | 505 |
| Depreciation Amortization | 45 | 4 | 119 | N/A | 119 |
| Accounts receivable | -27 | 63 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -32 | 445 | 65 | N/A | 22 |
| Other Working Capital | 1,392 | 1,190 | 3 | N/A | 14 |
| Other Operating Activity | 154,454 | -294 | -1,023 | 0 | -808 |
| Operating Cash Flow | $-8,481 | $-1,368 | $-497 | $N/A | $-149 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | N/A | -2,200 | N/A | N/A |
| Net Acquisitions | 1,955 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -81 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $1,870 | $N/A | $-2,200 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,200 | N/A | N/A | N/A | N/A |
| Debt Repayment | -6,200 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 15,826 | 150 | 2,657 | 4,668 | N/A |
| Common Stock Repurchased | N/A | N/A | -52 | N/A | -27 |
| Other Financing Activity | -1,899 | -906 | 0 | -4,668 | 0 |
| Financing Cash Flow | $13,927 | $-756 | $2,606 | $N/A | $-27 |
| Beginning Cash Position | 3,946 | 3,946 | 200 | N/A | 200 |
| End Cash Position | 11,262 | 1,822 | 108 | N/A | 24 |
| Net Cash Flow | $7,316 | $-2,124 | $-92 | $N/A | $-176 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,481 | -1,368 | -497 | N/A | -149 |
| Capital Expenditure | -4 | N/A | -2,200 | N/A | N/A |
| Free Cash Flow | -8,485 | -1,368 | -2,697 | 0 | -149 |